Every year at CES, companies showcase cutting-edge medical technology that introduces new solutions to problems and diseases that have plagued humanity since the event began, and 2025 is the year that regenerative medicine shines. During a panel discussion at CES 2025 moderated by Jason Haider, CEO and founder of Xenco Medical, and Veerle Dhaenens, general manager of Global Therapy Innovations at Terumo BCT, the two experts said that the world is at a “tipping point – a time where it is different. Technology areas have all reached a point where they can work together.
Digital Trends received compensation for coverage of these products. The brand had no influence on the editorial content and had no influence on the reporting.
Haider called it a “1965 moment,” alluding to the year Gordon Moore published Moore’s Law. Moore's Law is based on the idea that the number of transistors on a chip doubles every two years. It served as a metaphor for how quickly technology was evolving, but also led to the semiconductor revolution.
Haider believes regenerative medicine is facing a similar moment. With the rapid growth of artificial intelligence, more advanced computer simulation experiments, 3D printing, and a deeper understanding of medical science such as gene editing and protein folding theory, modern medicine is capable of achievements that would have been thought impossible in the past.
Jeremy Kaplan/Digital Trends/Brainco
Xenco Medical aims to “calibrate” recovery by providing only the amount of biomaterials – substances that help return the body to its natural state – that is necessary. By limiting the amount, Xenco can reduce the risk of side effects such as unwanted bone growth.
Please enable JavaScript to view this content
The company also hopes for a “cascade” regeneration. In other words, the goal is to help the body go beyond its normal healing process. Xenco plans to offer surgeons a wide range of implants with different densities and growth factors so they can find the best solution for their patients.
These promises ultimately boil down to two major implications for the average person. The introduction of such technology could lead to more affordable treatments and help increase medical access within five to ten years while improving the effectiveness of these treatments.
NurPhoto/Getty Images
Xenco believes that the advancement of in silico studies – computer simulations that show how a drug or disease might affect a particular patient's body – is a core element for the future of medicine. The FDA has released a report saying that these trials are inevitable and that advances in AI technology will help accelerate the field's growth.
Dhaenens added that artificial intelligence could improve the success rate of certain procedures from 47% to 92% – a stunning jump.
The two also touched on COVID-19, saying that while the speed of the global response was tragic, it was a key factor in the development of medical technology.
Comments are closed.